North America Veterinary Endocrinology Market Size, Share & Trends Analysis Report By Route of Administration (Oral and Other routes), By Animal type (Dogs, Cats, and Other Animals), By Application, By Country and Growth Forecast, 2024 - 2031

North America Veterinary Endocrinology Market Size, Share & Trends Analysis Report By Route of Administration (Oral and Other routes), By Animal type (Dogs, Cats, and Other Animals), By Application, By Country and Growth Forecast, 2024 - 2031

The North America Veterinary Endocrinology Market would witness market growth of 6.1% CAGR during the forecast period (2024-2031).

The US market dominated the North America Veterinary Endocrinology Market by Country in 2023, and would continue to be a dominant market till 2031; thereby, achieving a market value of $129,898.9 Thousands by 2031. The Canada market is experiencing a CAGR of 8.5% during (2024 - 2031). Additionally, The Mexico market would exhibit a CAGR of 7.6% during (2024 - 2031).

The adoption of veterinary endocrinology practices has evolved significantly over the years, driven by advancements in diagnostic capabilities, treatment options, and a growing recognition of the importance of hormonal balance in animal health.

Additionally, developing sensitive and specific hormone assays has revolutionized the diagnosis of endocrine disorders in animals. Veterinarians can now accurately measure hormone levels in blood, urine, or saliva samples, allowing for early detection and precise characterization of hormonal imbalances.

As Canada’s pet population grows, there is a corresponding increase in hormonal disorders among companion animals. Conditions such as thyroid disorders, diabetes mellitus, and adrenal gland diseases become more prevalent, driving up the demand for specialized veterinary endocrinology services.

Based on Route of Administration, the market is segmented into Oral and Other routes. Based on Animal type, the market is segmented into Dogs, Cats, and Other Animals. Based on Application, the market is segmented into Pancreatic Disorders, and Other Disorders. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

List of Key Companies Profiled

• Dechra Pharmaceuticals PLC (EQT AB)
• Elanco Animal Health Incorporated
• Merck & Co., Inc.
• Boehringer Ingelheim International GmbH
• Zoetis, Inc.
• LLOYD, Inc.
• Covetrus, Inc. (Clayton, Dubilier & Rice, LLC)
• Mars, Inc. (Antech Diagnostics, Inc)

North America Veterinary Endocrinology Market Report Segmentation

By Route of Administration

• Oral and
• Other routes

By Animal Type

• Dogs,
• Cats, and
• Other Animals

By Application

• Pancreatic Disorders, and
• Other Disorders

By Country

• US
• Canada
• Mexico
• Rest of North America